Sari Fishman
Corporate Officer/Principal bij CAN-FITE BIOPHARMA LTD.
Vermogen: - $ op 31-03-2024
Profiel
Sari Fishman is a professional with a background in business development and clinical affairs.
She is currently working as the Vice President of Business Development at Can-Fite BioPharma Ltd.
She started this position in 2017.
Previously, she worked as the Director of Clinical Affairs at OphthaliX, Inc. Dr. Fishman holds a doctorate degree from Bar-Ilan University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
-.--% | 28-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Sari Fishman
Bedrijven | Functie | Begin |
---|---|---|
CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01-01-2014 |
Eerdere bekende functies van Sari Fishman
Bedrijven | Functie | Einde |
---|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Sari Fishman
Bar-Ilan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
Can-Fite BioPharma Ltd. |